Andrea Jackson
InvestorPartner at Northpond Ventures Β· Board director at Vizgen Β· Board director at Scitara Β· Board director at Outcomes4Me
Boston, Massachusetts
Writes $100K β $5M checks Β· typically $1.5M
About
Andrea Jackson is a partner at Northpond Ventures investing in life sciences and technology companies across drug development platforms, diagnostics, and care delivery. She brings both operating experience and investment expertise, having led a $1 billion division at PerkinElmer, participated in M&A at Merck Millipore and JPMorgan's healthcare group, and deployed capital across a portfolio exceeding 50 companies with multiple successful exits including Current Health, Codex, and 908 Devices. Jackson serves on company boards and combines operational background with institutional capital allocation experience.
ContactΒ· self-published, not guessed
Likely emailΒ· guessed from name + firm domain, not firm-published
- aβ’β’β’@npv.vcreveal100% confident
Board director at Vizgen
Intro paths
In turn, Andrea can intro founders to Vizgen's investors below.
Vizgen's investors Β· 4
Co-founders at Vizgen
Board director at Scitara
Intro paths
In turn, Andrea can intro founders to Scitara's investors below.
Board director at Outcomes4Me
Intro paths
In turn, Andrea can intro founders to Outcomes4Me's investors below.
Outcomes4Me's investors Β· 5
Co-founders at Outcomes4Me

Experience
- Northpond VenturesPartnercurrent2023 β present
- Northpond VenturesManaging Director, Director, Principal2020 β 2023Cambridge, MA
- Mitra Biotech / Farcast BiosciencesVice President Sales & Marketing2018 β 2020Greater Boston
- Various Life Science and Technology companiesAdvisor2015 β 2018Greater Boston
- PerkinElmerVice President Strategic Marketing & Business Development2010 β 2015Waltham, Massachusetts
- Merck MilliporeDirector, Commercial Development, Director Integration Office, Senior Manager Corporate Development2008 β 2011
- JPMorgan Chase & Co.Associate - Investment Banking2006 β 2008
Skills & more
+12 more
LeadershipNon-profitsStrategic ConsultingBusiness DevelopmentAnalyticsProduct ManagementPortfolio ManagementKey Account ManagementManagementStrategic PlanningMergers & AcquisitionsProduct DevelopmentFrom Andrea's professional profile.
Colleagues at Northpond Ventures
Network5
Investors connected to Andrea in public investor directories β a warm-intro map.
Frequently asked questions
- Who is Andrea Jackson?
- Andrea Jackson is a partner at Northpond Ventures investing in life sciences and technology companies across drug development platforms, diagnostics, and care delivery. She brings both operating experience and investment expertise, having led a $1 billion division at PerkinElmer, participated in M&A at Merck Millipore and JPMorgan's healthcare group, and deployed capital across a portfolio exceeding 50 companies with multiple successful exits including Current Health, Codex, and 908 Devices. Jackson serves on company boards and combines operational background with institutional capital allocation experience.
- Where does Andrea Jackson work?
- Andrea Jackson is Partner at Northpond Ventures and Board director at Vizgen and Board director at Scitara and Board director at Outcomes4Me.
- What check size does Andrea Jackson write?
- Andrea Jackson typically writes checks of $100K β $5M.
- Where did Andrea Jackson go to school?
- Andrea Jackson studied at Northwestern University - Kellogg School of Management (MBA, Finance); Washington University in St. Louis (B.A., Economics major).
Same school
Also attended Northwestern University - Kellogg School of Management577
+ 571 more
Also attended Washington University in St. Louis173
+ 167 more
Shared employers
Also worked at Northpond Ventures12
+ 6 more
Also worked at PerkinElmer7
+ 1 more
Also worked at Merck Millipore2
Also worked at JPMorgan Chase & Co.338
+ 332 more




































